Citation: | TAN Minying, DAI Chuanjing, LU Xuemin, et al. Proliferation and Anti-inflammatory Effects of Tremella fuciformis Polysaccharide on Human Chondrocytes[J]. Science and Technology of Food Industry, 2024, 45(1): 1−8. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2023060077. |
[1] |
SANCHEZ-LOPEZ E, CORAS R, TORRES A, et al. Synovial inflammation in osteoarthritis progression[J]. Nature Reviews Rheumatology,2022,18(5):258−275. doi: 10.1038/s41584-022-00749-9
|
[2] |
KRAUS V B, BLANCO F J, ENGLUND M, et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use[J]. Osteoarthritis Cartilage,2015,23(8):1233−41. doi: 10.1016/j.joca.2015.03.036
|
[3] |
SOHN D H, SOKOLOVE J, SHARPE O, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4[J]. Arthritis Research & Therapy,2012,14(1):R7. doi: 10.1186/ar3555
|
[4] |
YAO Q, WU X, TAO C, et al. Osteoarthritis:Pathogenic signaling pathways and therapeutic targets[J]. Signal Transduction and Targeted Therapy,2023,8(1):56. doi: 10.1038/s41392-023-01330-w
|
[5] |
KATZ J N, ARANT K R, LOESER R F. Diagnosis and treatment of hip and knee osteoarthritis:A review[J]. Jama,2021,325(6):568−578. doi: 10.1001/jama.2020.22171
|
[6] |
UEBELHART D, THONAR E J, ZHANG J, et al. Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit [J]. Osteoarthritis Cartilage, 1998, 6 Suppl A:6-13.
|
[7] |
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013:A systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet,2015,386(9995):743−800. doi: 10.1016/S0140-6736(15)60692-4
|
[8] |
LOSINA E, WEINSTEIN A M, REICHMANN W M, et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US[J]. Arthritis Care Res (Hoboken),2013,65(5):703−711. doi: 10.1002/acr.21898
|
[9] |
BROWN T D, JOHNSTON R C, SALTZMAN C L, et al. Posttraumatic osteoarthritis:A first estimate of incidence, prevalence, and burden of disease[J]. Journal of Orthop Trauma,2006,20(10):739−744. doi: 10.1097/01.bot.0000246468.80635.ef
|
[10] |
VAN DEN BOSCH M H J. Osteoarthritis year in review 2020:Biology[J]. Osteoarthritis Cartilage,2021,29(2):143−50. doi: 10.1016/j.joca.2020.10.006
|
[11] |
ARDEN N K, PERRY T A, BANNURU R R, et al. Non-surgical management of knee osteoarthritis:Comparison of ESCEO and OARSI 2019 guidelines[J]. Nature Reviews Rheumatology,2021,17(1):59−66. doi: 10.1038/s41584-020-00523-9
|
[12] |
HENROTIN Y, MARTY M, MOBASHERI A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?[J]. Maturitas,2014,78(3):184−187. doi: 10.1016/j.maturitas.2014.04.015
|
[13] |
WU D, HUANG Y, GU Y, et al. Efficacies of different preparations of glucosamine for the treatment of osteoarthritis:A meta-analysis of randomised, double-blind, placebo-controlled trials[J]. International Journal of Clinical Practice,2013,67(6):585−594. doi: 10.1111/ijcp.12115
|
[14] |
CLEGG D O, REDA D J, HARRIS C L, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis[J]. New England Journal of Medicine,2006,354(8):795−808. doi: 10.1056/NEJMoa052771
|
[15] |
DA COSTA B R, PEREIRA T V, SAADAT P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis:Network meta-analysis[J]. Bmj,2021,375:n2321.
|
[16] |
BANNURU R R, OSANI M C, VAYSBROT E E, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis[J]. Osteoarthritis Cartilage,2019,27(11):1578−1589. doi: 10.1016/j.joca.2019.06.011
|
[17] |
LANZA F L, CHAN F K, QUIGLEY E M. Guidelines for prevention of NSAID-related ulcer complications[J]. Am J Gastroenterol,2009,104(3):728−38.
|
[18] |
PENDLETON A, ARDEN N, DOUGADOS M, et al. EULAR recommendations for the management of knee osteoarthritis:Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)[J]. Annals of the Rheumatic Diseases,2000,59(12):936−944. doi: 10.1136/ard.59.12.936
|
[19] |
ZHANG S, TEO K Y W, CHUAH S J, et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis[J]. Biomaterials,2019,200:35−47. doi: 10.1016/j.biomaterials.2019.02.006
|
[20] |
YANG D, LIU Y, ZHANG L. Tremella polysaccharide:The molecular mechanisms of its drug action[J]. Progress In Molecular Biology and Translational Science,2019,163:383−421.
|
[21] |
ZHANG Y, ZHANG M, JIANG Y, et al. Lentinan as an immunotherapeutic for treating lung cancer:A review of 12 years clinical studies in China[J]. Journal of Cancer Research and Clinical Oncology,2018,144(11):2177−2186. doi: 10.1007/s00432-018-2718-1
|
[22] |
LEE J, HA S J, LEE H J, et al. Protective effect of Tremella fuciformis Berk extract on LPS-induced acute inflammation via inhibition of the NF-κB and MAPK pathways[J]. Food Funct,2016,7(7):3263−3272. doi: 10.1039/C6FO00540C
|
[23] |
XU Y, XIE L, ZHANG Z, et al. Tremella fuciformis polysaccharides inhibited colonic inflammation in dextran sulfate sodium-treated mice via Foxp3+T cells, gut microbiota, and bacterial metabolites[J]. Front Immunol,2021,12:648162. doi: 10.3389/fimmu.2021.648162
|
[24] |
SHEN T, DUAN C, CHEN B, et al. Tremella fuciformis polysaccharide suppresses hydrogen peroxide-triggered injury of human skin fibroblasts via upregulation of SIRT1[J]. Molecular Medicine Reports,2017,16(2):1340−1346. doi: 10.3892/mmr.2017.6754
|
[25] |
MA L, LIN Z B. Effect of tremella polysaccharide on IL-2 production by mouse splenocytes[J]. Yao Xue Xue Bao,1992,27(1):1−4.
|
[26] |
BRUYÈRE O, ALTMAN R D, REGINSTER J Y. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis:Evidence from real-life setting trials and surveys [J]. Seminars in Arthritis and Rheumatism, 2016, 45(4 Suppl):S12−7.
|
[27] |
REGINSTER J Y, VERONESE N. Highly purified chondroitin sulfate:A literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment[J]. Aging Clinical and Experimental Research,2021,33(1):37−47. doi: 10.1007/s40520-020-01643-8
|
[28] |
KUANG S, LIU L, HU Z, et al. A review focusing on the benefits of plant-derived polysaccharides for osteoarthritis[J]. International Journal of Biological Macromolecules,2023,228:582−593. doi: 10.1016/j.ijbiomac.2022.12.153
|
[29] |
AL-AZAB M, QAED E, OUYANG X, et al. TL1A/TNFR2-mediated mitochondrial dysfunction of fibroblast-like synoviocytes increases inflammatory response in patients with rheumatoid arthritis via reactive oxygen species generation[J]. Febs Journal,2020,287(14):3088−3104. doi: 10.1111/febs.15181
|
[30] |
KOURTIS A, ADAMOPOULOS P G, PAPALOIS A, et al. Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis[J]. Annals of Translational Medicine ,2018,6(12):243. doi: 10.21037/atm.2018.05.47
|
[31] |
CHARLIER E, DEROYER C, CIREGIA F, et al. Chondrocyte dedifferentiation and osteoarthritis (OA)[J]. Biochemical Pharmacology,2019,165:49−65. doi: 10.1016/j.bcp.2019.02.036
|
[32] |
KAPOOR M, MARTEL-PELLETIER J, LAJEUNESSE D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis[J]. Nature Reviews Rheumatology,2011,7(1):33−42. doi: 10.1038/nrrheum.2010.196
|
[33] |
DENG C, ZHOU Q, ZHANG M, et al. Bioceramic scaffolds with antioxidative functions for ROS scavenging and osteochondral regeneration[J]. Advanced Science(Weinh),2022,9(12):e2105727. doi: 10.1002/advs.202105727
|
[34] |
CHEN G, ZHAO H, MA S, et al. Circadian rhythm protein Bmal1 modulates cartilage gene expression in temporomandibular joint osteoarthritis via the MAPK/ERK pathway[J]. Front Pharmacol,2020,11:527744. doi: 10.3389/fphar.2020.527744
|
[35] |
LEPETSOS P, PAPAVASSILIOU K A, PAPAVASSILIOU A G. Redox and NF-κB signaling in osteoarthritis[J]. Free Radical Biology and Medicine,2019,132:90−100. doi: 10.1016/j.freeradbiomed.2018.09.025
|
[36] |
MOBASHERI A, BATT M. An update on the pathophysiology of osteoarthritis[J]. Annals of Physical and Rehabilitation Medicine,2016,59(5-6):333−339. doi: 10.1016/j.rehab.2016.07.004
|
[37] |
BUHRMANN C, BROCKMUELLER A, MUELLER A L, et al. Curcumin attenuates environment-derived osteoarthritis by Sox9/NF-κB signaling axis[J]. International Journal of Molecular Sciences,2021,22(14):7645. doi: 10.3390/ijms22147645
|
[38] |
BURR D B, GALLANT M A. Bone remodelling in osteoarthritis[J]. Nature Reviews Rheumatology,2012,8(11):665−673. doi: 10.1038/nrrheum.2012.130
|
[39] |
MEHANA E E, KHAFAGA A F, EL-BLEHI S S. The role of matrix metalloproteinases in osteoarthritis pathogenesis:An updated review[J]. Life Sciences,2019,234:116786. doi: 10.1016/j.lfs.2019.116786
|
[40] |
LATOURTE A, CHERIFI C, MAILLET J, et al. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis[J]. Annals of the Rheumatic Diseases,2017,76(4):748−755. doi: 10.1136/annrheumdis-2016-209757
|
[41] |
VLACHOGIANNI T, FIOTAKIS K, LORIDAS S, et al. Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer[J]. Lung Cancer (Auckl),2013,4:71−82.
|